BioSpace News Archive

Business

University Hospital Basel, Switzerland Transfuses First Two COVID-19 Patients With INTERCEPT Treated Coronavirus Convalescent Plasma

Cerus Corporation announced that the University Hospital Basel transfused the first two COVID-19 patients with INTERCEPT treated coronavirus convalescent plasma.

April 2, 2020
·
7 min read
Business

Rapid-Start COVID-19 Studies Delivered through Science 37 and Innovo Partnership

The new partnership will help accelerate the start-up time for clinical trials related to the COVID-19 pandemic

April 2, 2020
·
3 min read
Business

10x Genomics Appoints Kim Popovits to Board of DirectorsFormer Genomic Health CEO brings decades of healthcare experience to Board

10x Genomics, Inc. announced the appointment of Kim Popovits, former Chairman of the Board, President and Chief Executive Officer of Genomic Health, Inc., to the company’s Board of Directors.

April 2, 2020
·
4 min read
Drug Development

Following Positive Interim Analysis, VB-111 Global Study in Ovarian Cancer to Extend to Japan via Collaboration with NanoCarrier

VBL Therapeutics (Nasdaq: VBLT) today announced that following the positive interim analysis in the OVAL study, its Japanese licensee NanoCarrier Co., Ltd. (TSE Mothers: 4571), intends to extend the ongoing global Phase 3 OVAL clinical trial in ovarian cancer to patients in Japan.

April 2, 2020
·
5 min read
Sai Life Sciences Becomes First India-headquartered Company to Join Pharmaceutical Supply Chain Initiative (PSCI)

Sai Life Sciences, one of India’s fastest growing Contract Development & Manufacturing Organizations (CDMOs), today announced its induction into the Pharmaceutical Supply Chain Initiative (PSCI) membership as an ‘Associate Member’.

April 2, 2020
·
3 min read
Deals

Geron Provides COVID-19 Related Business Update

Geron Corporation announced an update to information from its March 12 year-end conference call related to the impact of the COVID-19 pandemic on the Company’s business, and described the measures being taken to protect the safety of Geron’s employees and patients in its clinical trials.

April 2, 2020
·
7 min read
BioMidwest

CAS Releases Open Access Dataset of Antiviral Chemical Compounds to Aid COVID-19 Discovery and Analysis

CAS, a division of the American Chemical Society specializing in scientific information solutions, is partnering with research and technology organizations worldwide to tackle the complex challenges presented by COVID-19.

April 2, 2020
·
2 min read
Genetown

NanoMosaic Announces Exclusive License to Nanoneedle Technology from Harvard

NanoMosaic L.L.C. announced it is commercializing technology for high-throughput, high-sensitivity analyte detection initially developed at Harvard University, through an exclusive license agreement with Harvard Office of Technology Development.

April 2, 2020
·
3 min read
Drug Development

Dermavant Completes Patient Enrollment for Two Phase 3 Clinical Trials of Tapinarof for the Treatment of Psoriasis

Dermavant Sciences announced the completion of patient enrollment in the company’s PSOARING 1 and PSOARING 2 clinical trials of tapinarof, a potential first-in-class, once-daily topical therapeutic aryl hydrocarbon receptor modulating agent, in adult patients diagnosed with plaque psoriasis.

April 2, 2020
·
5 min read
Noxopharm Investigating Potential COVID-19 Treatment

Noxopharm, a clinical-stage Australian oncology drug development company, has identified a clinical trial opportunity that could help reduce the mortality rate of COVID-19.

April 2, 2020
·
2 min read